OptimizeRx Corp Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
OptimizeRx Corp quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • OptimizeRx Corp Entity Common Stock, Shares Outstanding for the quarter ending August 9, 2024 was 18.3M shares, a 10.1% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 18.3M +1.68M +10.1% Aug 9, 2024 10-Q 2024-08-15
Q1 2024 18.2M +1.08M +6.34% Apr 12, 2024 10-K 2024-04-15
Q3 2023 18.2M +1M +5.83% Nov 10, 2023 10-Q 2023-11-14
Q2 2023 16.6M -1.39M -7.69% Aug 11, 2023 10-Q 2023-08-14
Q1 2023 17.1M -1.05M -5.8% Feb 28, 2023 10-K 2023-03-10
Q3 2022 17.2M -617K -3.47% Nov 3, 2022 10-Q/A 2023-03-10
Q2 2022 18M +404K +2.3% Aug 8, 2022 10-Q/A 2023-03-10
Q1 2022 18.2M +1.35M +8.01% Apr 29, 2022 10-Q/A 2023-03-10
Q3 2021 17.8M +2.66M +17.6% Nov 5, 2021 10-Q 2021-11-09
Q2 2021 17.6M +2.8M +18.9% Jul 30, 2021 10-Q 2021-08-04
Q1 2021 16.8M +2.17M +14.8% Mar 3, 2021 10-K 2021-03-08
Q3 2020 15.1M +935K +6.6% Nov 5, 2020 10-Q 2020-11-09
Q2 2020 14.8M +679K +4.81% Aug 3, 2020 10-Q 2020-08-05
Q1 2020 14.6M +2.54M +21% Mar 24, 2020 10-K 2020-03-26
Q3 2019 14.2M +2.16M +18% Nov 1, 2019 10-Q 2019-11-05
Q2 2019 14.1M +2.5M +21.5% Aug 3, 2019 10-Q 2019-08-07
Q1 2019 12.1M -17.5M -59.2% Mar 7, 2019 10-K 2019-03-12
Q3 2018 12M -17.3M -59% Oct 31, 2018 10-Q 2018-11-05
Q2 2018 11.6M -17.6M -60.2% Jul 31, 2018 10-Q 2018-08-07
Q1 2018 29.6M -101K -0.34% Apr 30, 2018 10-Q 2018-05-02
Q3 2017 29.3M -397K -1.34% Oct 31, 2017 10-Q 2017-11-02
Q2 2017 29.3M -403K -1.36% Jul 28, 2017 10-Q 2017-08-01
Q1 2017 29.7M +707K +2.43% Apr 30, 2017 10-Q 2017-05-03
Q3 2016 29.7M +654K +2.25% Nov 4, 2016 10-Q 2016-11-07
Q2 2016 29.7M +6.71M +29.2% Aug 5, 2016 10-Q 2016-08-08
Q1 2016 29M +29M Mar 10, 2016 10-K 2016-03-15
Q3 2015 29M +5.61M +24% Nov 11, 2015 10-Q 2015-11-12
Q2 2015 22.9M -413K -1.77% Aug 11, 2015 10-Q 2015-08-11
Q1 2015 0 -22.8M -100% Mar 31, 2015 10-Q 2015-05-14
Q3 2014 23.4M +8.9M +61.4% Nov 12, 2014 10-Q 2014-11-13
Q2 2014 23.4M +9.11M +63.9% Aug 11, 2014 10-Q 2014-08-14
Q1 2014 22.8M +8.58M +60.3% Mar 31, 2014 10-K 2014-03-31
Q3 2013 14.5M +271K +1.9% Nov 13, 2013 10-Q 2013-11-14
Q2 2013 14.3M +60K +0.42% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 14.2M +40K +0.28% Mar 31, 2013 10-Q 2013-05-15
Q3 2012 14.2M +40K +0.28% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 14.2M +223K +1.6% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 14.2M Mar 31, 2012 10-Q 2012-05-15
Q3 2011 14.2M Nov 14, 2011 10-Q/A 2011-11-23
Q2 2011 14M Jun 30, 2011 10-Q 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.